Status:
COMPLETED
The DETECT HCV Linkage to Care Trial
Lead Sponsor:
Denver Health and Hospital Authority
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Hepatitis C
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This aim of the DETECT HCV linkage trial compares two linkage to care intervention strategies among (1) newly diagnosed HCV positive patients from the emergency department (ED) and (2) those patients ...
Detailed Description
The investigators will perform a prospective pragmatic randomized effectiveness trial to compare 2 linkage-to-care strategies. Permuted block randomization with 2 strata (i.e., \<40 years of age or ac...
Eligibility Criteria
Inclusion
- ED patients who test positive for HCV antibodies
- ED patients who have discharged and confirmatory RNA result is positive
- Clinically stable per screening nurse or physician assessment
- Able to provide consent
- ED patients with untreated active HCV confirmed by the electronic medical record
Exclusion
- Younger than 18 years of age
- Prisoners
- Pregnant women
- Individuals that live out of state
- Unable to consent for care (e.g., altered mentation, critical illness or injury)
- Non English or Spanish speaking
- Have already participated in the trial
Key Trial Info
Start Date :
November 20 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 12 2024
Estimated Enrollment :
309 Patients enrolled
Trial Details
Trial ID
NCT04026867
Start Date
November 20 2019
End Date
July 12 2024
Last Update
April 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Denver Health Medical Center
Denver, Colorado, United States, 80204